AstraZeneca Upbeat On China Prospects For New Products

China continues to be the brightest star in AstraZeneca's emerging markets firmament amid some "softness" in other countries, and the UK group sees attractive prospects in the country for some of its innovative branded products.

More from China

More from Focus On Asia